A recent class action lawsuit unveiled shocking evidence of fraudulent practices by Monsanto regarding glyphosate research. Millions of documents revealed how the company manipulated scientific studies and regulatory processes, including ghostwriting reports that downplayed the cancer risks associated with their product. This compelling information sheds light on the extent of corporate deceit and its implications for public health and safety.
